JP2005528386A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005528386A5 JP2005528386A5 JP2003583335A JP2003583335A JP2005528386A5 JP 2005528386 A5 JP2005528386 A5 JP 2005528386A5 JP 2003583335 A JP2003583335 A JP 2003583335A JP 2003583335 A JP2003583335 A JP 2003583335A JP 2005528386 A5 JP2005528386 A5 JP 2005528386A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- pharmaceutical composition
- alkyl
- thiophene
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 16
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 201000010099 disease Diseases 0.000 claims 12
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 208000030507 AIDS Diseases 0.000 claims 5
- 208000023275 Autoimmune disease Diseases 0.000 claims 4
- 206010061218 Inflammation Diseases 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 230000004054 inflammatory process Effects 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 2
- 206010003591 Ataxia Diseases 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 206010006895 Cachexia Diseases 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 206010018364 Glomerulonephritis Diseases 0.000 claims 2
- 208000017604 Hodgkin disease Diseases 0.000 claims 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 2
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 2
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 206010043189 Telangiectasia Diseases 0.000 claims 2
- 208000036142 Viral infection Diseases 0.000 claims 2
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims 2
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000004404 heteroalkyl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 210000000056 organ Anatomy 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 208000037803 restenosis Diseases 0.000 claims 2
- 230000037380 skin damage Effects 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 208000009056 telangiectasis Diseases 0.000 claims 2
- 230000017423 tissue regeneration Effects 0.000 claims 2
- 230000009385 viral infection Effects 0.000 claims 2
- KUJULOCYRKRCQF-UHFFFAOYSA-N 2-(carbamoylamino)-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide Chemical compound C1=CC=C2C(SC(=C3C(N)=O)NC(=O)N)=C3CCC2=C1 KUJULOCYRKRCQF-UHFFFAOYSA-N 0.000 claims 1
- GJEMPVNMJRCUOG-UHFFFAOYSA-N 2-(carbamoylamino)-4h-indeno[1,2-b]thiophene-3-carboxamide Chemical compound C1=CC=C2C(SC(=C3C(N)=O)NC(=O)N)=C3CC2=C1 GJEMPVNMJRCUOG-UHFFFAOYSA-N 0.000 claims 1
- UXRWCIHSQLDBGZ-UHFFFAOYSA-N 2-(carbamoylamino)-8-methoxy-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide Chemical compound C12=CC(OC)=CC=C2CCC2=C1SC(NC(N)=O)=C2C(N)=O UXRWCIHSQLDBGZ-UHFFFAOYSA-N 0.000 claims 1
- WUHDVLMASIPJRD-UHFFFAOYSA-N 2-acetamido-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide Chemical compound C1=CC=C2C(SC(=C3C(N)=O)NC(=O)C)=C3CCC2=C1 WUHDVLMASIPJRD-UHFFFAOYSA-N 0.000 claims 1
- BXFFEWIOXWTCDW-UHFFFAOYSA-N 2-acetamido-4h-indeno[1,2-b]thiophene-3-carboxamide Chemical compound C1=CC=C2C(SC(=C3C(N)=O)NC(=O)C)=C3CC2=C1 BXFFEWIOXWTCDW-UHFFFAOYSA-N 0.000 claims 1
- KRTRWULDPYHNTG-UHFFFAOYSA-N 2-acetamido-7-bromo-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide Chemical compound BrC1=CC=C2C(SC(=C3C(N)=O)NC(=O)C)=C3CCC2=C1 KRTRWULDPYHNTG-UHFFFAOYSA-N 0.000 claims 1
- SNVCIZOAGQJHJP-UHFFFAOYSA-N 2-acetamido-7-methoxy-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide Chemical compound C1CC2=CC(OC)=CC=C2C2=C1C(C(N)=O)=C(NC(C)=O)S2 SNVCIZOAGQJHJP-UHFFFAOYSA-N 0.000 claims 1
- AAQADBFOLFOIOA-UHFFFAOYSA-N 2-amino-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide Chemical compound C1CC2=CC=CC=C2C2=C1C(C(=O)N)=C(N)S2 AAQADBFOLFOIOA-UHFFFAOYSA-N 0.000 claims 1
- MVDZYYJMBOXFJG-UHFFFAOYSA-N 2-amino-4h-indeno[1,2-b]thiophene-3-carboxamide Chemical compound C1C2=CC=CC=C2C2=C1C(C(=O)N)=C(N)S2 MVDZYYJMBOXFJG-UHFFFAOYSA-N 0.000 claims 1
- AJYWRFNQAGTRJU-UHFFFAOYSA-N 2-amino-7-bromo-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide Chemical compound C1CC2=CC(Br)=CC=C2C2=C1C(C(=O)N)=C(N)S2 AJYWRFNQAGTRJU-UHFFFAOYSA-N 0.000 claims 1
- URQIEAVHAXSJIA-UHFFFAOYSA-N 2-amino-7-methoxy-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide Chemical compound C1CC2=CC(OC)=CC=C2C2=C1C(C(N)=O)=C(N)S2 URQIEAVHAXSJIA-UHFFFAOYSA-N 0.000 claims 1
- TZXBQOSHTSHWBA-UHFFFAOYSA-N 2-amino-8-methoxy-4,5-dihydrobenzo[g][1]benzothiole-3-carboxamide Chemical compound C12=CC(OC)=CC=C2CCC2=C1SC(N)=C2C(N)=O TZXBQOSHTSHWBA-UHFFFAOYSA-N 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 102000003945 NF-kappa B Human genes 0.000 claims 1
- 108010057466 NF-kappa B Proteins 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 230000009266 disease activity Effects 0.000 claims 1
- 230000009977 dual effect Effects 0.000 claims 1
- 230000003176 fibrotic effect Effects 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- DAUYIKBTMNZABP-UHFFFAOYSA-N thiophene-3-carboxamide Chemical compound NC(=O)C=1C=CSC=1 DAUYIKBTMNZABP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37194602P | 2002-04-11 | 2002-04-11 | |
| PCT/US2003/011297 WO2003086309A2 (en) | 2002-04-11 | 2003-04-11 | NF-κB INHIBITORS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005528386A JP2005528386A (ja) | 2005-09-22 |
| JP2005528386A5 true JP2005528386A5 (cg-RX-API-DMAC7.html) | 2006-06-01 |
Family
ID=29250761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583335A Withdrawn JP2005528386A (ja) | 2002-04-11 | 2003-04-11 | NF−κB阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7183311B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1499605B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005528386A (cg-RX-API-DMAC7.html) |
| AR (1) | AR039280A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE373648T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003224941A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60316425T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2294276T3 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200403991A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003086309A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1556053A4 (en) | 2002-10-31 | 2006-04-19 | Amgen Inc | ANTI-INFLAMMATORY AGENTS |
| GB0400895D0 (en) * | 2004-01-15 | 2004-02-18 | Smithkline Beecham Corp | Chemical compounds |
| TW200616967A (en) * | 2004-06-24 | 2006-06-01 | Smithkline Beecham Corp | Novel indazole carboxamides and their use |
| WO2006036031A1 (ja) * | 2004-09-30 | 2006-04-06 | Takeda Pharmaceutical Company Limited | 縮合フラン誘導体およびその用途 |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| AR065804A1 (es) | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
| JP2010006717A (ja) * | 2008-06-24 | 2010-01-14 | Kyorin Pharmaceut Co Ltd | ジヒドロチエノ[2,3−e]インダゾール化合物 |
| US8354539B2 (en) | 2009-03-10 | 2013-01-15 | Glaxo Group Limited | Indole derivatives as IKK2 inhibitors |
| WO2011077502A1 (ja) * | 2009-12-21 | 2011-06-30 | 杏林製薬株式会社 | ジヒドロチエノ[2,3-e]インダゾール化合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7801074L (sv) * | 1977-02-08 | 1978-08-09 | Sandoz Ag | Organiska foreningar, deras framstellning och anvendning |
| DE4039734A1 (de) * | 1990-12-13 | 1992-06-17 | Basf Ag | Substituierte 2-aminothiophene enthaltende herbizide mittel |
| US5763609A (en) * | 1996-03-21 | 1998-06-09 | Neurogen Corporation | Certain pyrrolo pyridine-3-carboxamides; a new class of gaba brain receptor ligands |
| US6624177B1 (en) * | 1996-09-04 | 2003-09-23 | Warner-Lambert Company | Matrix metalloproteinase inhibitors and their therapeutic uses |
| TW416953B (en) * | 1996-09-25 | 2001-01-01 | Takeda Chemical Industries Ltd | Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use |
| JPWO2001094309A1 (ja) * | 2000-06-02 | 2004-02-05 | 塩野義製薬株式会社 | Pgd2/txa2両受容体拮抗性医薬組成物 |
| US6414013B1 (en) | 2000-06-19 | 2002-07-02 | Pharmacia & Upjohn S.P.A. | Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| CA2443135C (en) * | 2001-03-30 | 2010-07-13 | Allan R. Moorman | Pharmaceutically active compounds and methods of use |
| US7166639B2 (en) * | 2001-10-04 | 2007-01-23 | Smithkline Beecham Corporation | NF-κB inhibitors |
-
2003
- 2003-04-09 TW TW092108058A patent/TW200403991A/zh unknown
- 2003-04-09 AR ARP030101254A patent/AR039280A1/es not_active Application Discontinuation
- 2003-04-11 JP JP2003583335A patent/JP2005528386A/ja not_active Withdrawn
- 2003-04-11 US US10/510,841 patent/US7183311B2/en not_active Expired - Fee Related
- 2003-04-11 ES ES03721638T patent/ES2294276T3/es not_active Expired - Lifetime
- 2003-04-11 DE DE60316425T patent/DE60316425T2/de not_active Expired - Fee Related
- 2003-04-11 AT AT03721638T patent/ATE373648T1/de not_active IP Right Cessation
- 2003-04-11 EP EP03721638A patent/EP1499605B1/en not_active Expired - Lifetime
- 2003-04-11 AU AU2003224941A patent/AU2003224941A1/en not_active Abandoned
- 2003-04-11 WO PCT/US2003/011297 patent/WO2003086309A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006510676A5 (cg-RX-API-DMAC7.html) | ||
| JP2005506334A5 (cg-RX-API-DMAC7.html) | ||
| JP2007522142A5 (cg-RX-API-DMAC7.html) | ||
| AU2023226778B2 (en) | Heteroarylamidopyridinol derivative and pharmaceutical composition comprising same as active ingredient for prevention or treatment of autoimmune disease | |
| CN111989332A (zh) | 作为cdk抑制剂的大环化合物、其制备方法及其在医药上的应用 | |
| US20050014705A1 (en) | Coumarin derivatives useful as tnf alpha inhibitors | |
| JP2006182786A5 (cg-RX-API-DMAC7.html) | ||
| RU2005135016A (ru) | Производные хинолина в качестве ингибиторов фосфодиэстеразы | |
| CN1173959C (zh) | 在2 -位携带具有磺酰胺结构或砜结构的取代基的8, 8a -二氢茚并 [1,2-d ]噻唑衍生物、它们的制备方法和它们作为药物的用途 | |
| JP2006515859A5 (cg-RX-API-DMAC7.html) | ||
| JP2008508303A5 (cg-RX-API-DMAC7.html) | ||
| JP2011507888A5 (cg-RX-API-DMAC7.html) | ||
| JP2018150331A5 (cg-RX-API-DMAC7.html) | ||
| JP2009510044A5 (cg-RX-API-DMAC7.html) | ||
| JP2006509749A5 (cg-RX-API-DMAC7.html) | ||
| AU777569B2 (en) | Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments | |
| JP2013515752A5 (cg-RX-API-DMAC7.html) | ||
| KR20020079891A (ko) | 8a 위치에서 치환된8,8a-디하이드로-인데노[1,2-d]티아졸 유도체, 이의제조 방법 및 의약, 예를 들면, 식욕감퇴제로서의 이의 용도 | |
| AU2023255903A1 (en) | Use of hpk1 inhibitor in prevention and/or treatment of human pathogen infection | |
| RU2007102576A (ru) | Новые индаэолкарбоксамиды и их применение | |
| JP2007538031A5 (cg-RX-API-DMAC7.html) | ||
| JP2008512374A5 (cg-RX-API-DMAC7.html) | ||
| JP2004504308A5 (cg-RX-API-DMAC7.html) | ||
| WO2014075618A1 (zh) | 含有杂环的5-羟基吲哚类衍生物及其用途 | |
| ES2488821T3 (es) | Proceso de preparación de un compuesto antiviral |